A patient with terminal breast cancer is receiving 30 mg of sustained-release morphine every 12 hours. The patient reports sleeping poorly at night due to pain. Which of the following medications should be used?
Immediate-release opioid is the most appropriate medication for this patient.
In cases where patients experience poorly managed pain, especially during nighttime, an immediate-release opioid can provide rapid pain relief and improve sleep quality. This option is particularly suitable for patients with terminal cancer who may require more effective pain management.
Immediate-release opioids are designed for quick absorption and can offer prompt relief from breakthrough pain, which is essential for patients experiencing significant discomfort, such as those with terminal breast cancer. This medication can be administered in addition to sustained-release morphine to address pain that is not adequately controlled.
While a nighttime sedative may help with sleep, it does not address the underlying pain that is causing the patient to sleep poorly. Sedatives can mask symptoms but do not provide the necessary analgesic effect, which is crucial for managing pain effectively in terminally ill patients.
Anxiolytics can help manage anxiety, which might contribute to sleep disturbances; however, they do not alleviate physical pain. In this context, the primary issue is pain management, making anxiolytics an insufficient choice for the patient's needs.
Anti-inflammatory agents can be beneficial for pain relief in certain conditions but may not be effective for cancer-related pain, which often requires opioid treatment. They do not provide the same level of analgesia that opioids do, especially in cases of severe pain associated with terminal illness.
In managing terminal breast cancer pain, immediate-release opioids are essential for addressing breakthrough pain effectively. This choice allows for better sleep quality by directly targeting the pain, making it preferable over options like sedatives, anxiolytics, or anti-inflammatory agents that do not adequately tackle the patient's primary issue of uncontrolled pain.
Related Questions
View allA 16 French catheter with a 30 ml balloon was inserted in a patient fo...
The epidural infusion rate of morphine and bupivacaine has recently be...
Upon election of the Medicare Hospice Benefit, the hospice provides me...
Which of the following is considered a core service for a hospice Medi...
A patient with general debility has been on hospice for 11 months. Ove...
Related Quizzes
View allNo related quizzes currently available.
- ✓ 500+ Practice Questions
- ✓ Detailed Explanations
- ✓ Progress Analytics
- ✓ Exam Simulations